Search

Author/Creator Ruane, Peter

21. Sofosbuvir/Velpatasvir/Voxilaprevir for patients with HCV who previously received a Sofosbuvir/Velpatasvir‐containing regimen: Results from a retreatment study. Issue 6 (27th February 2019)

Authors:
Ruane, Peter; Strasser, Simone I.; Gane, Edward J.; Hyland, Robert H.; Shao, Jiang; Dvory‐Sobol, Hadas; Tran, Tram; Stamm, Luisa M.; Brainard, Diana M.; Nyberg, Lisa; Shafran, Stephen
Journal:
Journal of viral hepatitis
Issue:
Volume 26:Issue 6(2019)
Page Start:
770
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

22. Switching from efavirenz, emtricitabine, and tenofovir disoproxil fumarate to tenofovir alafenamide coformulated with rilpivirine and emtricitabine in virally suppressed adults with HIV-1 infection: a randomised, double-blind, multicentre, phase 3b, non-inferiority study. Issue 5 (May 2017)

Authors:
DeJesus, Edwin; Ramgopal, Moti; Crofoot, Gordon; Ruane, Peter; LaMarca, Anthony; Mills, Anthony; Martorell, Claudia T; de Wet, Joseph; Stellbrink, Hans-Jürgen; Molina, Jean-Michel; Post, Frank A; Valero, Ignacio Pérez; Porter, Danielle; Liu, YaPei; Cheng, Andrew; Quirk, Erin; SenGupta, Devi; Cao,...
Journal:
Lancet
Issue:
Volume 4:Issue 5(2017)
Page Start:
e205
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

23. Switching from tenofovir disoproxil fumarate to tenofovir alafenamide coformulated with rilpivirine and emtricitabine in virally suppressed adults with HIV-1 infection: a randomised, double-blind, multicentre, phase 3b, non-inferiority study. Issue 5 (May 2017)

Authors:
Orkin, Chloe; DeJesus, Edwin; Ramgopal, Moti; Crofoot, Gordon; Ruane, Peter; LaMarca, Anthony; Mills, Anthony; Vandercam, Bernard; de Wet, Joseph; Rockstroh, Jürgen; Lazzarin, Adriano; Rijnders, Bart; Podzamczer, Daniel; Thalme, Anders; Stoeckle, Marcel; Porter, Danielle; Liu, Hui C; Cheng, Andre...
Journal:
Lancet
Issue:
Volume 4:Issue 5(2017)
Page Start:
e195
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

24. Switching to fixed-dose bictegravir, emtricitabine, and tenofovir alafenamide from dolutegravir plus abacavir and lamivudine in virologically suppressed adults with HIV-1: 48 week results of a randomised, double-blind, multicentre, active-controlled, phase 3, non-inferiority trial. Issue 7 (July 2018)

Authors:
Molina, Jean-Michel; Ward, Douglas; Brar, Indira; Mills, Anthony; Stellbrink, Hans-Jürgen; López-Cortés, Luis; Ruane, Peter; Podzamczer, Daniel; Brinson, Cynthia; Custodio, Joseph; Liu, Hui; Andreatta, Kristen; Martin, Hal; Cheng, Andrew; Quirk, Erin
Journal:
Lancet
Issue:
Volume 5:Issue 7(2018)
Page Start:
e357
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

25. Tenofovir alafenamide plus emtricitabine versus abacavir plus lamivudine for treatment of virologically suppressed HIV-1-infected adults: a randomised, double-blind, active-controlled, non-inferiority phase 3 trial. Issue 4 (April 2018)

Authors:
Winston, Alan; Post, Frank A; DeJesus, Edwin; Podzamczer, Daniel; Di Perri, Giovanni; Estrada, Vicente; Raffi, François; Ruane, Peter; Peyrani, Paula; Crofoot, Gordon; Mallon, Patrick W G; Castelli, Francesco; Yan, Mingjin; Cox, Stephanie; Das, Moupali; Cheng, Andrew; Rhee, Martin S
Journal:
Lancet
Issue:
Volume 5:Issue 4(2018)
Page Start:
e162
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗